Sign up for the QMED & MD+DI Daily newsletter.
Is Medtech's Pulse Weak or Strong?Is Medtech's Pulse Weak or Strong?
EY’s Jim Welch joins MD+DI for a brand-new episode of Let’s Talk Medtech to discuss the findings in the Annual Pulse of the Industry Report.
Omar Ford
November 17, 2021
1 Min Read
Jim Welch, EY’s Global MedTech leader, Health Sciences and Wellness division
It’s been a trying time for nearly every industry because of the pandemic. However, it seems as if medtech is rising above these challenges.
Deal activity is up, and more companies seem to be going public. EY’s Annual Pulse of the Industry Report shows these trends and touches on the rise of Special Purpose Acquisition Company (SPAC) mergers.
Jim Welch, EY’s Global MedTech leader, Health Sciences and Wellness division, stops by the Let’s Talk Medtech podcast to break down these trends and discuss what they mean for the industry.
About the Author
You May Also Like
_(1).png?width=300&auto=webp&quality=80&disable=upscale)
.png?width=300&auto=webp&quality=80&disable=upscale)
